HDAC2 and hepatocellular carcinoma: In HCC-LM3 and SNU-449 cells, HDAC2 overexpression shortened the cell doubling time by 9.6 h and 12 h, respectively, whereas 3-MA treatment prolonged it by 33.6 h and 28.8 h (Fig. 3I and Fig. S2G, H).